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Strengths and limitations of this study
 ► A strength of this process evaluation protocol in-
cludes the use of implementation frameworks, in 
particular, a multidimensional approach to evalua-
tion and intervention fidelity assessment.
 ► This study applies quantitative and qualitative 
methods and an iterative approach to analysis to 
understand how the intervention is implemented in 
practice.
 ► This process evaluation will provide insight about 
uptake and barriers and facilitators to implementing 
a new model of care in general practice.
 ► A limitation of our approach is that interview find-
ings might not be generalisable to other settings.
 ► We have adapted our interview sampling approach 
to capture as broad a range of study involvement as 
possible and aimed to triangulate these data with 
other data sources, such as observations, question-
naires and routinely collected data.
AbStrACt
Introduction Primary care interventions are often 
multicomponent, with several targets (eg, patients and 
healthcare professionals). Improving Primary Care After 
Stroke (IPCAS) is a novel primary care- based model of 
long- term stroke care involving a review of stroke- related 
needs, a self- management programme, a direct point of 
contact in general practice, enhanced communication 
between care services, and a directory of national and 
local community services, currently being evaluated in 
a cluster randomised controlled trial (RCT). Informed 
by Medical Research Council guidance for complex 
interventions and the Behaviour Change Consortium 
fidelity framework, this protocol outlines the process 
evaluation of IPCAS within this RCT. The process evaluation 
aimed to explore how the intervention was delivered 
in context and how participants engaged with the 
intervention.
Methods and analysis Mixed methods will be used: 
(1) design: intervention content will be compared with 
‘usual care’; (2) training: intervention training sessions 
will be audio/video- recorded where feasible; (3) delivery: 
healthcare professional self- reports, audio recordings of 
intervention delivery and observations of My Life After 
Stroke course (10% of reviews and sessions) will be coded 
separately; semistructured interviews will be conducted 
with a purposive sample of healthcare professionals; (4) 
receipt and (5) enactment: where available, structured 
stroke review records will be analysed quantitatively; 
semistructured interviews will be conducted with a 
purposive sample of study participants. Self- reports, 
observations and audio/video recordings will be coded 
and scored using specifically developed checklists. 
Semistructured interviews will be analysed thematically. 
Data will be analysed iteratively, independent of primary 
endpoint analysis.
Ethics and dissemination Favourable ethical opinion 
was gained from Yorkshire & The Humber- Bradford 
Leeds NHS Research Ethics Committee (19 December 
2017, 17/YH/0441). Study results will be published 
in a peer- reviewed journal and presented at relevant 
conferences.
trial registration number NCT03353519; Pre- results.
IntroduCtIon
Stroke mortality is in decline, but remains a 
leading cause of disability.1–3 There are rising 
numbers of people with stroke living in the 
community, and with this comes increasing 
demand on primary care services to address 
long- term needs, such as cognitive, psycho-
logical and social problems.3 4 Strategies to 
address these long- term needs are limited, 
with stroke survivors and their caregivers often 
reporting a lack of support.3 5 Stroke preven-
tion is a priority for the National Health 
Service (NHS) in England,6 as most recently 
outlined in the NHS Long Term Plan, and 
internationally.6–9 Primary care services have 
tended to focus on secondary prevention of 
stroke and risk factor management10 11 rather 
than addressing the longer- term needs,5 and 
no formal primary care- based model of care 
exists to support community- dwelling stroke 
survivors.
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Figure 1 Interventions and outcomes. GP, general practitioner.
The Improving Primary Care After Stroke (IPCAS) 
cluster randomised controlled trial (RCT) aims to eval-
uate the clinical and cost effectiveness of a new model 
of primary care for stroke survivors living in the commu-
nity compared with standard care and has been described 
previously.12 General practices randomised to the inter-
vention arm will deliver a multicomponent package of 
care comprising a one- off structured review with a trained 
primary care professional using a novel needs check-
list,13 a self- management course (My Life After Stroke 
(MLAS)) conducted by trained facilitators over a 9- week 
period, which aims to improve confidence, indepen-
dence and hope in survivors of stroke through problem- 
solving and experience and knowledge exchange with 
course participants; enhanced communication between 
healthcare professionals; and a direct point of contact 
in primary care accessible to patients for stroke- specific 
support throughout the study period. General practices 
randomised to the control arm will provide ‘usual care’, 
the details of which will be documented as part of this 
process evaluation (see the Fidelity of design section). 
The primary endpoint will be two subscales (emotion and 
handicap) of the Stroke Impact Scale V.3.014 as coprimary 
outcomes at 12 months after entry into the trial. The 
intervention and outcomes are summarised in figure 1.
Complex interventions are widely used to address health 
problems and consist of multiple interacting compo-
nents,15 16 often with several targets (eg, patients and 
healthcare professionals) and implemented in various 
settings.17 18 Consequently, variations in implementa-
tion could influence intervention effects on outcomes. 
Process evaluations are especially important for RCTs, 
such as IPCAS, which is being conducted in 46 general 
practices in the East of England and the East Midlands. 
These practices have contextual differences, and thus, 
the intervention may undergo adaptations as the study is 
conducted.18 19 It also has intervention components that 
are aimed at stroke survivors, as well as healthcare profes-
sionals. This warrants a multifaceted process evaluation 
to identify successes, failures and/or unintended conse-
quences.15 20 21 Understanding the delivery of complex 
interventions is key to determining the feasibility of deliv-
ering these in other settings and at scale.17 As such, the 
present evaluation was developed alongside IPCAS and 
will be conducted in parallel with it.
The UK Medical Research Council suggests that process 
evaluations are conducted to understand how interventions 
are carried out, how intervention activities produce change 
and how the context in which interventions are conducted 
influences delivery.18 19 In line with this, the US National 
Institute of Health Behaviour Change Consortium’s (BCC) 
fidelity framework and guidance specify five dimensions of 
treatment fidelity: (1) design: the degree to which the inter-
vention is distinct (eg, through articulated intervention 
components and theoretical underpinning) from usual 
care or other treatment conditions; (2) training: the extent 
to which the training of intervention providers is adequate 
through monitoring training processes and activities; (3) 
delivery: the extent to which intervention components 
and/or procedures are provided as planned; (4) receipt: 
the extent to which intervention recipients understand and 
engage with intervention components; and (5) enactment: 
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Table 1 Assessing intervention fidelity in the IPCAS trial
Fidelity of design Fidelity of training Fidelity of delivery
Fidelity of engagement (receipt 
and enactment)
Goal
 ► To determine the extent to 
which the intervention reflects 
its theoretical underpinnings.
 ► To determine the extent 
to which the training 
curriculum has been 
provided as planned.
 ► To determine the extent 
to which the intervention 
was provided as planned.
 ► To determine the extent 
to which stroke survivors 
understood and applied 
the skills gained from the 
intervention.
 ► To determine the extent to 
which the intervention is 
distinct from ‘usual care’.
      
Strategies
 ► Coding intervention 
components (ie, IPCAS 
training manual and MLAS 
curriculum) to theoretical 
underpinnings.
 ► Training evaluation forms 
(MLAS).
 ► Audio- recorded 
observations (IPCAS).
 ► Self- report questionnaire 
(MLAS).
 ► Comparison of convergence 
between intervention and 
control groups (includes 
recording of participating 
surgeries’ usual care 
practices).
 ► Video- recorded 
observations (MLAS).
 ► Structured telephone 
calls to healthcare 
professionals (IPCAS).
 ► Postreview structured 
telephone calls to participants 
(IPCAS).
 ► Audio- recorded 
observations (IPCAS).
 ► Direct observations 
(MLAS).
 ► Postintervention participant 
interviews.
 ► Postintervention 
interviews (healthcare 
professionals, IPCAS).
 ► Postintervention 
interviews (IPCAS).
  
IPCAS, Improving Primary Care After Stroke; MLAS, My Life After Stroke.
the extent to which intervention recipients carry out 
specific/relevant behaviours learnt from the intervention 
in their daily lives.22 23
This paper outlines the aims, design and methods for 
an embedded process evaluation within an RCT. This 
process evaluation is a multidimensional assessment of 
the IPCAS trial, specifically to explore (1) how the inter-
vention was delivered, (2) how participants engaged with 
the intervention and (3) if/how the context influenced 
delivery or conduct of the intervention.
MEthodS And AnAlySIS
design
A mixed- methods sequential design will be applied. 
The process evaluation (encompassing intervention 
fidelity) will be conducted in parallel to the IPCAS trial. 
Table 1 outlines how the five BCC fidelity dimensions 
will be addressed in IPCAS. Each of these dimensions—
design, training, delivery, engagement (enactment and 
receipt)—are discussed in turn, including relevant mate-
rials and data collection processes. These are followed 
by the patient and public involvement (PPI) and analysis 
plans.
Fidelity of design
This concerns the completeness of the intervention speci-
fication and the degree to which the intervention reflects 
its theoretical foundations.20 22 All IPCAS intervention 
components are defined in the trial protocol,12 some of 
which are standardised (eg, structured review checklist 
for use in a one- off, face- to- face annual stroke review) 
and some are not, in order to allow participants and 
practices flexibility to adapt these components to their 
needs (eg, accessing direct point of contact and MLAS, 
enhanced communication between healthcare profes-
sionals). The intervention development process involved 
a multidisciplinary team (general practitioners (GPs), 
patient representatives, primary care experts, applied 
health researchers, psychologists, stroke physicians, prac-
tice nurses and therapists), with pilot work informing the 
feasibility and acceptability of the intervention.12 13
To ensure that the intervention reflects its theoretical 
underpinnings and is distinct from usual care, the inter-
vention components (eg, structured reviews and MLAS) 
and parameters (eg, frequency or dose, mode of delivery 
and duration) will be coded and compared by two indepen-
dent coders in accordance with established methods.20 22 
As such, all participating general practices will be asked to 
provide details of usual care processes for stroke care and 
long- term follow- up, such as the frequency and content of 
follow- up appointments, healthcare professionals respon-
sible for these, investigations conducted (eg, blood tests, 
blood pressure and pulse measurements) and other 
actions taken (eg, referrals or further investigations). 
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Inter- rater reliability will be assessed using Cohen’s kappa 
(95% CI).24 Where intervention components of similar 
frequency and/or mode of delivery are found in both 
conditions, these will be classed as fully convergent; where 
intervention components are found in both experimental 
conditions but are of dissimilar frequency and/or mode 
of delivery, these will be classed as partially convergent; and 
where intervention components are found only in one 
arm of the study, these will be classed as unique.20 More-
over, adaptations to the intervention will be recorded and 
monitored by the research team throughout the inter-
vention period through maintaining a written record of 
these in the fidelity of delivery assessments (detailed in 
the following subsections).
Fidelity of training
Participating general practices will be given a 2- hour 
face- to- face training session where the research team will 
present the intervention components and facilitate discus-
sions on how to conduct the intervention using fictional 
vignettes. A sample of the training sessions (20%, up to 
four sessions) will be audio- recorded, with two raters 
assessing whether planned components are present using 
a specifically developed checklist (online supplemen-
tary file 1). Randomly- selected training sessions will be 
audio- recorded (with participant consent) after the fifth 
training session when trainers have had an opportunity 
to test their curriculum and materials, and adjustments 
will be made where necessary. The percentage of present 
planned components will be calculated, and inter- 
rater agreement will be assessed using Cohen’s kappa 
(95% CI).24 MLAS facilitators will be trained via a 3- day 
workshop, with the research team delivering presenta-
tions on stroke and its impact, providing trainees time 
to practise active listening skills, explaining the philos-
ophy and theories underpinning the self- management 
course, demonstrating MLAS facilitation and providing 
an opportunity for trainees to rehearse course delivery. 
MLAS training will be video- recorded and coded by an 
independent rater according to a priori criteria (online 
supplementary file 2) to assess whether planned compo-
nents are present. In addition, trainees will be encouraged 
to complete training evaluation forms, to assess facili-
tator knowledge of the MLAS curriculum and expected 
facilitator behaviours (online supplementary file 3). 
The percentage of present planned components will be 
calculated. To ensure skills are maintained, refresher 
training sessions will be offered as necessary. MLAS facil-
itators will receive mentoring from researchers as part 
of their training package after having had an opportu-
nity to deliver a programme. Qualitative interviews with 
healthcare providers conducting structured reviews will 
explore their experiences of intervention training (see 
the Fidelity of delivery section). Finally, process variables 
such as the number of healthcare professionals and facil-
itators trained, and the duration of training sessions will 
be recorded and summarised.
Fidelity of delivery
Monitoring intervention delivery is critical to ensuring 
that the intervention is provided as planned; this will be 
conducted using quantitative and qualitative methods. 
The BCC guidance suggests that evaluating intervention 
sessions by observation (either directly or using audio/
video- recording) is the gold standard for monitoring 
intervention delivery.22 23 To achieve this, a sample of 
the structured stroke reviews will be audio- recorded 
and coded by two independent raters according to a 
prespecified checklist (online supplementary file 4), 
which outlines the specific intervention components 
which healthcare providers are expected to cover. A 
sample of structured reviews carried out (up to 10% or 46 
30- min reviews across all intervention sites) will be audio- 
recorded at each practice. With participant consent, some 
reviews will be recorded after the fifth review has been 
conducted at each practice, which allows for healthcare 
professionals to rehearse and become familiarised with 
review components. Fidelity of delivery will be assessed by 
calculating the percentage of the prespecified structured 
review content that is present. Inter- rater reliability will 
be assessed using Cohen’s kappa (95% CI).24 To enable 
further exploration of delivery, healthcare professionals 
will be contacted by members of the research team regu-
larly during the intervention period to discuss the struc-
tured reviews and to monitor whether the intervention 
being delivered is as planned, with responses recorded 
using a prespecified checklist (see online supplemen-
tary file 4). These data will be quantified by calculating 
the percentage of present prespecified structured review 
content. Additionally, reasons for (eg, lack of time) and 
the nature of (eg, additional support provided) devia-
tions from the developed intervention will be explored 
and documented through conducting interviews. A 
purposively selected sample (approximate n=15, 10 inter-
vention and 5 control) of healthcare professionals will 
be invited to participate in semistructured interviews to 
explore their overall experience of delivering the inter-
vention (intervention) or participation in the study 
(control) in depth. Specifically, interviews will explore 
healthcare professionals’ reflections on their experience 
of conducting the structured review, the functionality of 
the direct point of contact and service mapping tool, and 
their overall experience of the intervention (eg, what 
worked well vs what did not work well). Interviews will 
run for approximately 30 min–1 hour. These interviews 
are planned to take place from the 6- month follow- up 
period. Recruitment and data collection will cease when 
adequate data addressing our evaluation aim have been 
acquired25 26 (see the Analysis plan section).
MLAS courses will also be assessed for fidelity of delivery. 
Specific contents of this self- management programme 
are provided in the IPCAS trial protocol.12 A sample 
(ie, two full MLAS courses, approximately 20 hours of 
observation) of preselected sessions of running MLAS 
programmes will be directly observed independently 
by two observers, with disagreements resolved through 
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consensus discussion. These observers will have been 
trained in course delivery and observation. A specially 
developed observation checklist (online supplementary 
file 5) will be used to code for the presence or absence 
of intended course contents, materials and facilitator 
behaviours. Fidelity will be quantified by assessing the 
proportion of presence of prespecified content (ie, % 
coded components/planned components). These obser-
vations are planned to take place after MLAS facilitators 
have received mentoring; we also aimed to observe all 
facilitators running MLAS courses at least once. MLAS 
facilitator–participant interactions will also be observed 
using the Diabetes Education and Self- Management for 
Ongoing and Newly Diagnosed (DESMOND) observa-
tion tool (online supplementary file 6), in line with simi-
larly designed courses.27
Finally, process variables will be collected to assess 
delivery and summarised for each participating general 
practice, such as practice list size, role of healthcare 
professional conducting reviews, the number of patients 
attending structured reviews, duration of each structured 
review conducted, number and content of referrals/sign-
posting to other services and number of MLAS courses 
conducted. These fidelity of delivery assessments and 
process measures will offer an insight into differences in 
intervention delivery between practices.
Fidelity of receipt and enactment (engagement)
Fidelity of receipt and enactment (engagement), which 
concerns understanding of intervention content and 
application of skills gained from the intervention, respec-
tively,22 28 will be assessed concurrently as both encom-
pass participant engagement28 both quantitatively and 
qualitatively. Similar to the process outlined for assessing 
fidelity of delivery, patients will be contacted by members 
of the research team to discuss the structured reviews they 
were invited to. Predetermined questions concerning the 
structured review will be asked and recorded on a check-
list (online supplementary file 7). This will be quantified 
by calculating the percentage of the present prespecified 
structured review content. Concerning MLAS, a purpo-
sively selected sample of participants (ie, 10% of partici-
pants attending MLAS, approximately 20) will be invited 
to complete a specially developed receipt questionnaire 
(online supplementary file 8) at the end of each session 
attended (ie, six per participant in total). If necessary, 
participants will be offered support in completing this.
Qualitative semistructured interviews with study partic-
ipants (approximately n=25, 15 intervention and 10 
control) will be conducted to explore their understanding 
and experience of the new model of care (intervention 
arm), and their care experiences since involvement in 
the trial (control arm). Participants will be selected using 
a random purposive method, given the large pool of 
eligible participants (eg, those who attended structured 
reviews and MLAS and those who did not), which will 
allow us to gain representative insights.29 Interviews will 
run for approximately 30 min–1 hour. These interviews 
are expected to take place from the 6- month follow- up 
period. Specifically, participants will be asked about any 
action plans they developed with healthcare professionals 
during their structured review and the outcomes of these, 
experiences of accessing the direct point of contact for 
their needs, as well as participation in MLAS. Interviews 
with control group participants will focus on any stroke- 
specific appointments/contacts with the GP or practice 
staff since involvement in the study and any perceived 
changes in their care during this period. These different 
areas of focus will allow for an exploration of differences 
within and between experimental arms. Recruitment and 
data collection will cease when adequate data addressing 
our evaluation aim have been acquired25 26 (see the Anal-
ysis plan section).
In addition, process variables will be collected routinely, 
such as the number of patients invited and consented, 
demographic characteristics, time since stroke, number 
of patients attending structured reviews, number of 
patients completing the checklist of needs, number of 
participants enrolled in MLAS (defined as attending 
the first individual appointment and first group session) 
and number of participants completing MLAS (defined 
as attending both individual appointments and at least 
three of the four group sessions).
Patient and public involvement
Protocol and materials development involved PPI. A PPI 
member provided feedback on the process evaluation 
protocol to ensure procedures (eg, recruitment and 
data collection) in place are appropriate and relevant. 
For example, PPI consultation resulted in changes to 
the format and length of the questionnaires for MLAS, 
ensuring that the questionnaire is aphasia friendly. 
Together, we decided to brief facilitators about providing 
stroke survivors support in completing questionnaires 
where needed. Our PPI member was also involved in 
pilot- testing the interview schedule with a member of the 
research team, which ensured that the interview schedule 
was suitable and flexible (eg, addition of closed question 
prompts for people with aphasia).
Analysis plan
The process evaluation analysis will be undertaken sepa-
rately to the trial outcome evaluation and will inform the 
interpretation of these data. Quantitative aspects of the 
process evaluation (eg, observational data and checklists/
questionnaires) will be assessed using descriptive statistics 
(ie, proportions, frequencies and means) and percentage 
implementation scores on various BCC fidelity dimen-
sions. This will enable us to examine variation in imple-
mentation between GP practices at regular intervals. It is 
suggested that a score of 80%–100% is representative of 
‘high’ intervention fidelity; 51%–79% is representative of 
‘moderate’ intervention fidelity; and <50% is representa-
tive of ‘low’ intervention fidelity.30 Qualitative aspects of 
the process evaluation include audio- recorded interview 
data and textual data (ie, qualitative data from checklists/
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questionnaires). All data will be transcribed verbatim. 
Interview data will be synthesised using thematic anal-
ysis by members of the research team using established 
methods.25 This will also involve an iterative comparison 
of participant and healthcare professional interview 
data to understand similarities and differences between 
intervention providers and recipients. Textual data from 
checklists and questionnaires will be analysed using 
content analysis. NVivo V.12 will be used to support qual-
itative data management and analysis.
The quantitative and qualitative analyses will be 
conducted and integrated at different phases of the 
evaluation. For example, we will compare findings from 
different data sources such as participants’ self- reported 
receipt and enactment questionnaires, and healthcare 
professionals’ self- reported delivery questionnaires with 
the audio- recorded observations of the structured stroke 
reviews.
Ethics and dissemination
Favourable ethical opinion for the research was gained 
on 19 December 2017 from Yorkshire & The Humber- 
Bradford Leeds NHS Research Ethics Committee. 
Approval to start was given by the Health Research 
Authority on 21 December 2017, prior to the recruitment 
of participants commencing at any NHS site. Process eval-
uation findings will be published in peer- reviewed jour-
nals and presented at relevant academic conferences.
dISCuSSIon
This multifaceted process evaluation aimed to comple-
ment the effectiveness testing of a theory- driven complex 
intervention. It will generate knowledge concerning how 
and why this novel model of primary care- based stroke 
care could have an impact, thereby informing ways of 
scaling up the intervention and implementing the model 
in other settings as part of usual care. Specifically, the 
present intervention contains adaptable components as 
it is implemented pragmatically; therefore, process eval-
uation findings can offer an insight into how this model 
of care contributes to the evidence base by illustrating 
the extent to which a high level of fidelity is useful or 
necessary.
It has been suggested that there are four possible 
scenarios as to the contribution of process evaluation 
findings to investigating how interventions are effective 
or not20: (1) successful intervention/high fidelity, where 
trial outcomes demonstrate improvements in the inter-
vention group and treatment fidelity is deemed ‘high’, 
which increases confidence in associating trial outcomes 
with the intervention delivered; (2) successful inter-
vention/low fidelity, where trial outcomes demonstrate 
improvements in the intervention group and treatment 
fidelity is deemed ‘low’, which suggests that there may 
have been confounding factors, or mechanisms of action 
through which the intervention operated which were not 
identified and assessed; (3) unsuccessful intervention/
high fidelity: where trial outcomes demonstrate no 
improvements in the intervention group and treatment 
fidelity is deemed ‘high’, which supports the conclusion 
that the intervention was not effective, or could have been 
influenced by confounding factors; and (4) unsuccessful 
intervention/low fidelity: where trial outcomes demon-
strate no improvements in the intervention group and 
treatment fidelity is deemed ‘low’, which suggests that 
the intervention was not tested as it was not carried out 
as planned, or that poor intervention fidelity could have 
negatively impacted intervention outcomes.
It is recommended that process evaluation proto-
cols are reported and published to encourage trans-
parency.17–20 The protocol described here builds on 
emerging process evaluation methodology literature, 
which can inform the development and implementa-
tion of complex interventions.
trial status
At the time of submission, the IPCAS trial recruitment 
is ongoing, with the target sample size of 920 surpassed 
in March 2019. The IPCAS process evaluation started in 
March 2018 alongside general practice recruitment, with 
the fidelity of design and training data collection and 
analysis commencing in July 2018. Pilot observations and 
interviews were conducted in February–March 2019, with 
ongoing iterative analysis.
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